- 询价
- abinScience
- China
- HF515073
- 2026年03月03日
- ELISA, FuncS
- Human
- Human, Mouse, Rat
企业认证
相关产品推荐更多 >
Research Grade Amlitelimab, 研究级Amlitelimab
￥2288
Anti-Human CD110/MPL Antibody (VB22B), PE, 抗人CD110/MPL抗体 (VB22B), PE标记
询价
Anti-Human TSHR/LGR3 Antibody (K1-70), PerCP, 抗人TSHR/LGR3抗体 (K1-70), PerCP标记
询价
Anti-Natalizumab Neutralizing Recombinant Antibody (SAA2878), 抗Neutralizing Recombinant 抗体 (SAA2878)
询价
Anti-Human CD27 Monoclonal Antibody (1A688), 抗人CD27 Monoclonal抗体 (1A688)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
/
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Mouse, Rat
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
HF515073
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Human
- 应用范围：
ELISA, FuncS
- 浓度：
/
- 靶点：
EC:3.2.1.18, NA, Neuraminidase
- 抗体英文名：
Anti-Collagen II Antibody (SAA2702)
- 抗体名：
Anti-Collagen II Antibody (SAA2702)
- 规格：
50ug/100ug/1mg
| Product name | Anti-Collagen II Antibody (SAA2702) |
|---|---|
| Catalog No. | HF515073 |
| Host species | Human |
| Species reactivity | Human, Mouse, Rat |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Concentration | / |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Applications | ELISA, FuncS |
| Target | EC:3.2.1.18, NA, Neuraminidase |
| References | / |
| Purification | Protein A/G purified from cell culture supernatant. |
| Biological activity | / |
| Endotoxin level | <10 EU/mg |
| Expression system | / |
| Accession | P02458,P28481,P05539 |
| Label | / |
| Protein length | / |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Reconstitution | / |
| Detection method | / |
| Alternative Names | / |
| Clone ID | SAA2702 |
| Note | For research use only |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验CUSABIO季度文献盘点：二季度新增600篇产品引用文献，总文献数量已达 31400篇！
(IgG) ELISA Kit; CSB-E11194mMouse anti-nuclear Antibody (IgG) ELISA Kit; CSB-E12912m 研究亮点 甲羟戊酸通路产物GGPP通过GGTase II催化RAB35香叶基香叶基化，促进CXCR5循环至细胞膜，维持T滤泡辅助细胞表面分子表达与分化。TCR信号经SREBP2、EGR1和E2F1增强该通路，在狼疮中异常活跃。他汀类药物抑制该通路，减轻自身免疫，提示代谢调控Tfh细胞的新机制。 05
Nucleic Acid Programmable Protein Arrays: Versatile Tools for Array‐Based Functional Protein Studies
on NAPPA Slides with Anti‐GST Antibody Support Protocol 4: Pretitration for Signal Stabilization Reagents and Solutions Commentary Literature Cited
Nature重磅技术TransTAC选中的受体！TFR1这个铁转运蛋白要火了
研究前景 TFR1的临床转化呈现多元化格局。在ADC药物方面，CX-2029是首--个靶向CD71的Probody-药物偶联物（PDC），通过蛋白酶激活设计限制正常组织暴露，在I期临床试验中展现首--个人体抗肿瘤活性，目前持续临床评估中。在双特异性抗体方面，trontinemab（RO7126209）为抗Aβ/抗TfR1双抗，利用TFR1介导的跨血脑屏障转胞吞递送抗体至中枢，脑摄取提升4-18倍，已进入II期用于阿尔茨海默病。在蛋白降解领域，TransTAC技术利用TFR1循环内吞实现膜蛋白高效降解
技术资料暂无技术资料 索取技术资料
